SS

Saurabh Sharma

Active Director Director DIN 11430659
DIN 11430659 First appointment Dec 2025 Primary industry Wood
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value •••• Premium profile

About Saurabh Sharma

Data last updated:

Saurabh Sharma is a Director at Reydis Pharmaceuticals Private Limited (since 2025). The company operates in Wood. Reydis Pharmaceuticals Private Limited reported revenue of ₹9.9 Lakh (FY 2025).

DIN 11430659
Primary Designation Director
Industry Wood
First Appointment 16 Dec 2025
Largest company Reydis Pharmaceuticals Private Limited · ₹9.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Dec 2025₹9.9 Lakh (FY 2025)Active

Board colleagues of Saurabh Sharma

NameDINCompanyDesignation
Deepak Kumar Jain10069736Reydis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Reydis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Saurabh Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saurabh Sharma

Saurabh Sharma currently holds 1 directorship: Reydis Pharmaceuticals Private Limited (Director, since 16 Dec 2025, revenue ₹9.9 Lakh (FY 2025)).

Saurabh Sharma was first appointed on 16 Dec 2025 as Director at Reydis Pharmaceuticals Private Limited.

The current boards of Saurabh Sharma's companies include Deepak Kumar Jain (Reydis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available